NCT02043652View on ClinicalTrials.gov

Plasmodium Vivax Efficacy Trial in Cruzeiro do Sul, Acre, Brazil

NACompletedINTERVENTIONAL

Enrollment

119

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Malaria

Interventions

DRUG

Chloroquine

Patients will receive 3-day treatment with chloroquine in accordance to treatment guidelines in Brazil. All patients will receive the same treatment as there is no comparison arm.

DRUG

Primaquine

Patients will receive 7-day treatment with primaquine, in conjunction with chloroquine, in accordance to treatment guidelines in Brazil. All patients will receive the same treatment as there is no comparison arm.

Trial Locations (1)

Unknown

Hospital do Jurua, Cruzeiro do Sul

All Listed Sponsors

lead

Centers for Disease Control and Prevention

FED

NCT02043652 - Plasmodium Vivax Efficacy Trial in Cruzeiro do Sul, Acre, Brazil | Biotech Hunter | Biotech Hunter